Stay updated on Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page
- CheckyesterdayChange DetectedThe study record now shows Terminated status with participation details and the Informed Consent Form PDF added to the study documents, while the previous Active, not recruiting status was removed.SummaryDifference0.7%

- Check8 days agoChange DetectedThe page now shows an updated site revision/version identifier (from v3.5.2 to v3.5.3), indicating a background update to the ClinicalTrials.gov interface rather than a change to the clinical trial record.SummaryDifference0.1%

- Check15 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check44 days agoChange DetectedResults data were posted, including radiographic RECIST responses, pathologic response, adverse events, and survival outcomes with timing details. The update also references the associated study documents and submission dates.SummaryDifference3%

- Check51 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the study page.SummaryDifference0.1%

- Check80 days agoChange DetectedA minor site revision was issued (Revision: v3.4.2), replacing the previous v3.4.1 and removing the government funding lapse notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page.